Anebulo Pharmaceuticals (ANEB) Non Operating Income (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) reported Non Operating Income of $620,513 for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 395.9% from $125,121 a year earlier and up 508.9% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Non Operating Income (2020 - 2025) Analysis & Trends
Over the twelve months ended Dec 31, 2025, Anebulo Pharmaceuticals' Non Operating Income came in at $1.12 million, up 233.1% year-over-year; for FY2025 (ended Jun 30, 2025), it was $738,718, up 590.1% from FY2024.
- Non Operating Income has increased for three consecutive fiscal years.
- By fiscal year, Non Operating Income came in at $107,052 in FY2024 (+108.8%), $51,261 in FY2023 (+822.8%), $5,555 in FY2022 and -$26.64 million in FY2021.
- The fiscal Q2 2026 figure ranks as the highest quarterly Non Operating Income in data going back to fiscal Q1 2021.
- Year over year, Non Operating Income gained in three of the last five quarters, with growth averaging 137.4%.
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $101,906 (Q1 2026), $186,056 (Q4 2025) and $216,153 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Anebulo Pharmaceuticals | 11.50 Mn | -32.80 Mn | - | 620,513.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 620,513.00 |
| Sep 30, 2025 | 101,906.00 |
| Jun 30, 2025 | 186,056.00 |
| Mar 31, 2025 | 216,153.00 |
| Dec 31, 2024 | 125,121.00 |
| Sep 30, 2024 | 211,388.00 |
| Jun 30, 2024 | -9,602.00 |
| Mar 31, 2024 | 10,709.00 |
| Dec 31, 2023 | 43,090.00 |
| Sep 30, 2023 | 62,855.00 |
| Jun 30, 2023 | -1,191.00 |
| Mar 31, 2023 | 66,070.00 |
| Dec 31, 2022 | -13,830.00 |
| Sep 30, 2022 | -212.00 |
| Jun 30, 2022 | 2,742.00 |
| Mar 31, 2022 | 3,153.00 |
| Sep 30, 2021 | 1,529.00 |
| Jun 30, 2021 | -26.63 Mn |
| Mar 31, 2021 | -3,701.00 |
| Sep 30, 2020 | -4,033.00 |
API Access
Anebulo Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();